Suhail M. Ali

2.8k total citations
78 papers, 1.9k citations indexed

About

Suhail M. Ali is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Suhail M. Ali has authored 78 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Oncology, 31 papers in Pulmonary and Respiratory Medicine and 21 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Suhail M. Ali's work include HER2/EGFR in Cancer Research (21 papers), Bone health and treatments (16 papers) and Peptidase Inhibition and Analysis (14 papers). Suhail M. Ali is often cited by papers focused on HER2/EGFR in Cancer Research (21 papers), Bone health and treatments (16 papers) and Peptidase Inhibition and Analysis (14 papers). Suhail M. Ali collaborates with scholars based in United States, Austria and Portugal. Suhail M. Ali's co-authors include Allan Lipton, Kim Leitzel, Walter P. Carney, Laurence M. Demers, Harold A. Harvey, Marian Dynis, Lawrence T. Goodnough, Kim Leitzel, Rainer Neumann and Linda Engle and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Suhail M. Ali

74 papers receiving 1.8k citations

Peers

Countries citing papers authored by Suhail M. Ali

Since Specialization

Citations

This map shows the geographic impact of Suhail M. Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suhail M. Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suhail M. Ali more than expected).

Fields of papers citing papers by Suhail M. Ali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suhail M. Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suhail M. Ali. The network helps show where Suhail M. Ali may publish in the future.

Co-authorship network of co-authors of Suhail M. Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Suhail M. Ali. A scholar is included among the top collaborators of Suhail M. Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suhail M. Ali. Suhail M. Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cellular Fitness Phenotypes of Cancer Target Genes from Oncobiology to Cancer Therapeutics 2021 ·Cells ·Bijesh George, (unknown), (unknown), (unknown), Kim Leitzel, Suhail M. Ali, Oleta A. Sandiford, Allan Lipton, Pranela Rameshwar, Gabriel N. Hortobágyi, Madhavan Radhakrishna Pillai, Rakesh Kumar	5
2	Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancer 2019 ·Scientific Reports ·Nicholas Willumsen, Suhail M. Ali, Kim Leitzel, Joseph J. Drabick, Nelson S. Yee, (unknown), (unknown), (unknown), Sajid Ali, (unknown), (unknown), (unknown), (unknown), Harry Menon, (unknown), Luís Costa, M.A. Karsdal, Allan Lipton	44
3	Population‐based differences in the outcome and presentation of lung cancer patients based upon racial, histologic, and economic factors in all lung patients and those with metastatic disease 2018 ·Cancer Medicine ·John M. Varlotto, (unknown), (unknown), John C. Flíckinger, Malcolm M. DeCamp, Debra Maddox, Paul Rava, Thomas J. FitzGerald, (unknown), (unknown), Paulo J. Oliveira, Suhail M. Ali, Chandra P. Belani, (unknown), Heather A. Wakelee, Manali I. Patel, Jennifer Baima, Jianying Zhang, William Walsh	23
4	Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab) 2017 ·Breast Cancer Research and Treatment ·(unknown), Jessica Huang, J. W. Chapman, Kim Leitzel, Suhail M. Ali, Lois E. Shepherd, Wendy R. Parulekar, Catherine Ellis, (unknown), Liting Zhu, Shakeel Virk, Dora Nomikos, Samuel Aparício, Karen A. Gelmon, Walter P. Carney, Allan Lipton	11
5	Consolidation With Radiation or Concurrent Chemo-Radiation After Chemotherapy Results in Durable Complete Remissions of Isolated Nodal Recurrences of Urothelial Cancer: A Case Series and Review 2016 ·Clinical Genitourinary Cancer ·(unknown), Heath B. Mackley, Suhail M. Ali, Henry Wagner, Monika Joshi, Sheldon L. Holder, M. Kaag, (unknown), Giampaolo Talamo, Joseph J. Drabick	2
6	Antiresorptive Therapy in the Management of Cancer Treatment-Induced Bone Loss 2015 ·Current Osteoporosis Reports ·(unknown), Kim Leitzel, Suhail M. Ali, Allan Lipton	12
7	Impact of Genetic Targets on Prostate Cancer Therapy 2012 ·Advances in experimental medicine and biology ·(unknown), Junaid Abdulghani, Suhail M. Ali, Raghu Sinha, (unknown)	2
8	Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression‐free survival in patients with HER2‐positive metastatic breast cancer receiving lapatinib monotherapy 2011 ·Cancer ·Allan Lipton, Kim Leitzel, Suhail M. Ali, Walter P. Carney, (unknown), Klaudia Steplewski, Ron E. Westlund, Robert Gagnon, Anne‐Marie Martin, J. Maltzman	19
9	Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization‐positive patients with metastatic breast cancer treated with trastuzumab 2010 ·Cancer ·Allan Lipton, Wolfgang J. Köstler, Kim Leitzel, Suhail M. Ali, Jeff Sperinde, Jodi Weidler, Agnès Paquet, Thomas Sherwood, Weidong Huang, Michael Bates, (unknown)	38
10	Elevated plasma tissue inhibitor of metalloproteinase‐1 levels predict decreased survival in castration‐resistant prostate cancer patients 2010 ·Cancer ·William Oh, Roberto Vargas, Susanna Jacobus, Kim Leitzel, Meredith M. Regan, Peter Hamer, Karen Pierce, Sheryl Brown‐Shimer, Walter P. Carney, Suhail M. Ali, Philip W. Kantoff, Allan Lipton	31
11	Serum HER‐2/neu and relative resistance to trastuzumab‐based therapy in patients with metastatic breast cancer 2008 ·Cancer ·Suhail M. Ali, Walter P. Carney, Francisco J. Esteva, Monica Fornier, Lyndsay N. Harris, Wolfgang J. Köstler, Jean‐Pierre Lotz, Diana Lüftner, (unknown), Allan Lipton	63
12	HER-2 therapy. HER-2/neu diagnostics in breast cancer 2007 ·Breast Cancer Research ·Walter P. Carney, Kim Leitzel, Suhail M. Ali, Rainer Neumann, Allan Lipton	40
13	Elevated plasma tissue inhibitor of metalloproteinase‐1 level predicts decreased response and survival in metastatic breast cancer 2007 ·Cancer ·Allan Lipton, Suhail M. Ali, Kim Leitzel, Laurence M. Demers, Dean B. Evans, Peter Hamer, Sheryl Brown‐Shimer, Karen Pierce, Walter P. Carney	40
14	Serum HER‐2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy 2005 ·Cancer ·Allan Lipton, Kim Leitzel, Suhail M. Ali, Laurence M. Demers, Harold A. Harvey, Hilary A. Chaudri‐Ross, Dean B. Evans, (unknown), Wolfgang Hackl, Peter Hamer, Walter P. Carney	81
15	Monitoring the Circulating Levels of the HER2/neu Oncoprotein in Breast Cancer 2004 ·Clinical Breast Cancer ·Walter P. Carney, Rainer Neumann, Allan Lipton, Kim Leitzel, Suhail M. Ali, Christopher P. Price	61
16	Serum HER-2/neu and Response to the Aromatase Inhibitor Letrozole Versus Tamoxifen 2003 ·Journal of Clinical Oncology ·A. Lipton, Suhail M. Ali, Kim Leitzel, L. Demers, Harold A. Harvey, Hilary A. Chaudri‐Ross, C. Brady, P.J. Wyld, Walter P. Carney	102
17	Serum HER-2/neu and response to the aromatase inhibitor letrozole versus tamoxifen 2001 ·Breast Cancer Research and Treatment ·Allan Lipton, Suhail M. Ali, Kim Leitzel, Daniel F. Hayes	18
18	Economic Impact of Donor Platelet Count and Platelet Yield in Apheresis Products: Relevance for Emerging Issues in Platelet Transfusion Therapy 1999 ·Vox Sanguinis ·Lawrence T. Goodnough, Suhail M. Ali, George Despotis, Marian Dynis, John F. DiPersio	24
19	Prevalence of HLA sensitization in female apheresis donors 1999 ·Transfusion ·(unknown), Lawrence T. Goodnough, Suhail M. Ali, Marian Dynis, (unknown)	181
20	Role of thymectomy in myasthenia gravis. 1992 ·PubMed ·Suhail M. Ali, (unknown), (unknown), Irfan Altafullah, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact